|
Volumn 32, Issue 6, 2010, Pages 410-414
|
[GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B7 ANTIGEN;
CANCER VACCINE;
CD40 ANTIGEN;
CD86 ANTIGEN;
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HLA ANTIGEN CLASS 2;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ADENOVIRUS;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
CELL PROLIFERATION;
CYTOLOGY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY;
DENDRITIC CELL;
FEMALE;
GENETIC TRANSFECTION;
GENETICS;
IMMUNOLOGY;
METABOLISM;
MOUSE;
PATHOLOGY;
SECRETION;
STOMACH TUMOR;
TUMOR CELL LINE;
ADENOVIRIDAE;
ANIMALS;
ANTIGENS, CD40;
ANTIGENS, CD80;
ANTIGENS, CD86;
CANCER VACCINES;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYTOTOXICITY, IMMUNOLOGIC;
DENDRITIC CELLS;
FEMALE;
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
INTERFERON-GAMMA;
MICE;
MICE, INBRED BALB C;
STOMACH NEOPLASMS;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSFECTION;
|
EID: 79957495301
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|